ClearSpec has announced that it has entered into a distribution agreement with McKesson Medical-Surgical (McKesson) for distribution of the company's new device, the ClearSpec single use vaginal speculum to physicians' offices, home care agencies, long-term care facilities and surgery centers in the US.
Pursuant to the terms of the distribution agreement, McKesson will have rights to sell the ClearSpec vaginal speculum in non-acute care markets.
ClearSpec founder and CEO Navroze Mehta said: "Since presenting the ClearSpec Speculum at the AAGL and ACOG Conferences, ClearSpec has received significant interest in the distribution of this product and is very pleased to have selected McKesson as its distribution ally, one of the best names in health care quality in the world."
This patented and the US Food and Drug Administration (FDA) cleared ClearSpec speculum is scientifically proven to improve visualization of the cervix for every exam.
ClearSpec addresses the problem of proper visualization of the cervix for the diagnosis and treatment of cervical disease, improving outcomes for women.
The ClearSpec study "Sheathed versus standard speculum for visualization of the cervix" is being published in the May 2014 Issue of a highly regarded Journal, the International Journal of Gynecology and Obstetrics.